Other frequent means of MYC deregulation are chromosomal translocations, enhanced mRNA stability, altered post-translational modifications, and dysregulation of upstream signalling pathways (Dang, 2012), reflecting the selective pressure on tumours to elevate MYC activity through whatever means available, reinforcing its critical role in malignant transformation and progression. The gene discussed is MYC; the disease is neoplasm.